InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
3
已披露卖出
1
T+90 胜率
100%
T+90 平均收益
+34.3%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the full record of transactions filed by Davidson Michael H., 董事. Director active across 3 companies, notably Tenax Therapeutics, INC.. Cumulatively, 10 disclosures have been published. Breakdown: 3 buys · 1 sell. Total volume traded: €154k. History available since 10 January 2022. The latest transaction was disclosed on 26 March 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Davidson Michael H.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
443,707 股Ordinary SharesSEC:0001193125-26-085947:0
64,708 股Ordinary SharesSEC:0001193125-26-078718:0
11,582 股Ordinary SharesSEC:0001193125-26-009272:0
30,992 股0Ordinary SharesSEC:0000950170-25-046934:0
123,529 股Ordinary SharesSEC:0000950170-25-003022:0
5,000 股@ US$16.2747.6% 占其流量Ordinary SharesSEC:0000950170-24-099871:0
标准退出：2024年11月18日 (T+90)
2,500 股Common StockSEC:0001654954-24-010192:0
标准退出：2024年11月6日 (T+90)
5,000 股@ US$17.261752.4% 占其流量Ordinary SharesSEC:0000950170-24-076468:0
标准退出：2024年9月18日 (T+90)
65,430 股0Common StockSEC:0001573785-22-000002:0
512,000 股Common StockSEC:0001654954-21-006926:0
10 条申报中的 10 条
About Davidson Michael H.
Davidson Michael H. is a Director and has 10 filings in total. Across the 10 recent filings we hold, from 2021-06-15 to 2026-03-02, the record shows EUR 153718 of purchases and EUR 0 of sales, mainly in NewAmsterdam Pharma Co N.V., with roles also at Tenax Therapeutics, INC. and Caladrius Biosciences, INC.
